375 related articles for article (PubMed ID: 30054781)
1. Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
Kuriyama A; Urushidani S
Heart Fail Rev; 2019 Jan; 24(1):31-39. PubMed ID: 30054781
[TBL] [Abstract][Full Text] [Related]
2. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Wu MY; Chang NC; Su CL; Hsu YH; Chen TW; Lin YF; Wu CH; Tam KW
J Crit Care; 2014 Feb; 29(1):2-9. PubMed ID: 24331943
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of continuous vs intermittent infusion of loop diuretics in hospitalized patients.
Alqahtani F; Koulouridis I; Susantitaphong P; Dahal K; Jaber BL
J Crit Care; 2014 Feb; 29(1):10-7. PubMed ID: 23683555
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Ng KT; Yap JLL
Anaesthesia; 2018 Feb; 73(2):238-247. PubMed ID: 28940440
[TBL] [Abstract][Full Text] [Related]
5. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis.
Bagshaw SM; Delaney A; Haase M; Ghali WA; Bellomo R
Crit Care Resusc; 2007 Mar; 9(1):60-8. PubMed ID: 17352669
[TBL] [Abstract][Full Text] [Related]
6. Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Thomson MR; Nappi JM; Dunn SP; Hollis IB; Rodgers JE; Van Bakel AB
J Card Fail; 2010 Mar; 16(3):188-93. PubMed ID: 20206891
[TBL] [Abstract][Full Text] [Related]
7. Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.
Salvador DR; Rey NR; Ramos GC; Punzalan FE
Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD003178. PubMed ID: 16034890
[TBL] [Abstract][Full Text] [Related]
8. Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials.
Amer M; Adomaityte J; Qayyum R
J Hosp Med; 2012 Mar; 7(3):270-5. PubMed ID: 22125127
[TBL] [Abstract][Full Text] [Related]
9. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
10. Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial.
Frea S; Pidello S; Volpe A; Canavosio FG; Galluzzo A; Bovolo V; Camarda A; Golzio PG; D'Ascenzo F; Bergerone S; Rinaldi M; Gaita F
Clin Res Cardiol; 2020 Apr; 109(4):417-425. PubMed ID: 31256261
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Use of Hypertonic Saline and IV Furosemide for Fluid Overload: A Systematic Review and Meta-Analysis.
Liu C; Peng Z; Gao X; Gajic O; Dong Y; Prokop LJ; Murad MH; Kashani KB; Domecq JP
Crit Care Med; 2021 Nov; 49(11):e1163-e1175. PubMed ID: 34166286
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
Kissling KT; Pickworth KK
Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
[TBL] [Abstract][Full Text] [Related]
13. Diuretic strategies in patients with acute decompensated heart failure.
Felker GM; Lee KL; Bull DA; Redfield MM; Stevenson LW; Goldsmith SR; LeWinter MM; Deswal A; Rouleau JL; Ofili EO; Anstrom KJ; Hernandez AF; McNulty SE; Velazquez EJ; Kfoury AG; Chen HH; Givertz MM; Semigran MJ; Bart BA; Mascette AM; Braunwald E; O'Connor CM;
N Engl J Med; 2011 Mar; 364(9):797-805. PubMed ID: 21366472
[TBL] [Abstract][Full Text] [Related]
14. Continuous versus bolus intermittent loop diuretic infusion in acutely decompensated heart failure: a prospective randomized trial.
Palazzuoli A; Pellegrini M; Ruocco G; Martini G; Franci B; Campagna MS; Gilleman M; Nuti R; McCullough PA; Ronco C
Crit Care; 2014 Jun; 18(3):R134. PubMed ID: 24974232
[TBL] [Abstract][Full Text] [Related]
15. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
[TBL] [Abstract][Full Text] [Related]
16. Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Sharma K; Vaishnav J; Kalathiya R; Hu JR; Miller J; Shah N; Hill T; Sharp M; Tsao A; Alexander KM; Gupta R; Montemayor K; Kovell L; Chasler JE; Lee YJ; Fine DM; Kass DA; Weiss RG; Thiemann DR; Ndumele CE; Schulman SP; Russell SD;
JACC Heart Fail; 2018 Oct; 6(10):859-870. PubMed ID: 30098962
[TBL] [Abstract][Full Text] [Related]
17. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Singh D; Shrestha K; Testani JM; Verbrugge FH; Dupont M; Mullens W; Tang WH
J Card Fail; 2014 Jun; 20(6):392-9. PubMed ID: 24704538
[TBL] [Abstract][Full Text] [Related]
18. [Diuretic therapy in acute heart failure].
Trullàs JC; Morales-Rull JL; Formiga F
Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
[TBL] [Abstract][Full Text] [Related]
19. Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction.
Zheng Z; Jiang X; Chen J; He D; Xie X; Lu Y
ESC Heart Fail; 2021 Jun; 8(3):2070-2078. PubMed ID: 33689236
[TBL] [Abstract][Full Text] [Related]
20. Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical Studies.
Covic A; Copur S; Tapoi L; Afsar B; Ureche C; Siriopol D; Nistor I; Kanbay M
Am J Cardiovasc Drugs; 2021 May; 21(3):331-347. PubMed ID: 33210263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
